Jazz Pharmaceuticals Archives -

Trial of Jazz’ cannabis drug in glioblastoma will start next year

https://pharmaphorum.com/news/trial-of-jazz-cannabis-drug-in-hard-to-treat-glioblastoma-will-start-next-year/

Jazz lifted by third EU approval for GW Pharma’s Epidyolex

https://pharmaphorum.com/news/jazz-lifted-by-third-eu-approval-for-gw-pharmas-epidyolex/

Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma

https://pharmaphorum.com/news/jazz-agrees-7-2bn-deal-to-buy-cannabis-meds-pathfinder-gw-pharma/

Harmony’s sleep disorder drug Wakix gets US label extension

https://pharmaphorum.com/news/harmonys-narcolepsy-drug-gets-extended-cataplexy/

FDA approves Jazz Pharmaceuticals’ narcolepsy therapy

https://pharmaphorum.com/news/fda-approves-jazz-pharmaceuticals-narcolepsy-therapy/

Jazz targets US launch of SCLC drug after FDA grants fast review

https://pharmaphorum.com/news/jazz-targets-us-launch-of-sclc-drug-after-fda-grants-fast-review/

PharmaMar and Jazz sign $1bn US deal for lung cancer drug lurbinectedin

https://pharmaphorum.com/news/pharmamar-and-jazz-sign-1bn-us-deal-for-lung-cancer-drug/

Novartis’ Mayzent, Roche’s Polivy head latest crop of CHMP approvals

https://pharmaphorum.com/news/novartis-mayzent-roches-polivy-head-latest-crop-of-chmp-approvals/

Priority review voucher prices fall again after Spark’s $110m sale

https://pharmaphorum.com/news/spark-sells-priority-review-voucher-to-jazz/

Search